4.8 Article

Breast Cancer Statistics, 2022

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Oncology

American Cancer Society's report on the status of cancer disparities in the United States, 2021

Farhad Islami et al.

Summary: This report provides comprehensive data on disparities in cancer occurrence, risk factors, and access to preventive measures and screening in the US. Policy recommendations are made to reduce these inequalities, emphasizing the need for broad implementation of evidence-based interventions to address social inequities and systemic racism.

CA-A CANCER JOURNAL FOR CLINICIANS (2022)

Article Oncology

Cancer statistics, 2022

Rebecca L. Siegel et al.

Summary: Each year, the American Cancer Society compiles data on cancer occurrence and outcomes in the United States. The latest data shows that breast and prostate cancer progress has stagnated, while lung cancer has shown improvements in survival rates. Lung cancer incidence for advanced disease has declined while localized-stage rates have increased, resulting in higher survival rates. Mortality patterns align with incidence trends, with lung cancer deaths declining rapidly, breast cancer deaths slowing, and prostate cancer deaths stabilizing.

CA-A CANCER JOURNAL FOR CLINICIANS (2022)

Article Oncology

Cancer statistics for African American/Black People 2022

Angela N. Giaquinto et al.

Summary: African American/Black individuals bear a disproportionate cancer burden, with high mortality and low survival rates compared to other racial/ethnic groups. Data from the American Cancer Society shows that in 2018, there were significant disparities in cancer incidence, mortality, survival, screening, and risk factors among Black people in the United States. The projected numbers for 2022 indicate a high number of new cancer cases and deaths among Black individuals. Black men have higher incidence and mortality rates for certain cancers, such as myeloma, stomach cancer, and prostate cancer. The disparity in overall cancer mortality between Black and White men is narrowing, but the decline in prostate cancer mortality among Black men has slowed. Black women have a lower incidence rate but higher mortality rates for certain cancers, such as endometrial and breast cancer. Breast cancer has become the leading cause of cancer death among Black women.

CA-A CANCER JOURNAL FOR CLINICIANS (2022)

Article Oncology

Early Local Therapy for the Primary Site in De Novo Stage IV Breast Cancer: Results of a Randomized Clinical Trial (EA2108)

Seema A. Khan et al.

Summary: Early locoregional therapy for the primary site did not improve survival in patients with metastatic breast cancer, but it was associated with improved locoregional control without impacting overall quality of life.

JOURNAL OF CLINICAL ONCOLOGY (2022)

Article Medicine, General & Internal

Event-free Survival with Pembrolizumab in Early Triple-Negative Breast Cancer

P. Schmid et al.

Summary: The addition of pembrolizumab to neoadjuvant chemotherapy followed by adjuvant pembrolizumab after surgery significantly prolonged event-free survival in patients with early triple-negative breast cancer.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

Review Oncology

Emerging strategies for TNBC with early clinical data: new chemoimmunotherapy strategies

Peter E. Hall et al.

Summary: The review highlights the complexity of chemoimmunotherapy strategies for triple-negative breast cancer, emphasizing the importance of considering the type and sequence of chemotherapy agents to optimize the response to immune checkpoint inhibitors. The emerging therapeutic class of antibody-drug conjugates in combination with immune checkpoint inhibitors shows promise for the treatment of triple-negative breast cancer.

BREAST CANCER RESEARCH AND TREATMENT (2022)

Article Oncology

Racial disparity in distant recurrence-free survival in patients with localized breast cancer: A pooled analysis of National Surgical Adjuvant Breast and Bowel Project trials

Gina Kim et al.

Summary: Black women with estrogen receptor-positive (ER+) localized breast cancer have worse distant relapse-free survival (DRFS) outcomes compared to White women, but there is no significant difference in ER- disease outcomes. Racial disparity is also observed in patients with residual ER+ breast cancer after neoadjuvant chemotherapy but not in those with complete response.

CANCER (2022)

Article Oncology

Decreasing Incidence of Estrogen Receptor-Negative Breast Cancer in the United States: Trends by Race and Region

Brittny C. Davis Lynn et al.

Summary: The incidence of ER-negative breast cancer has decreased from 1992 to 2016 in all age groups and racial or ethnic groups. The greatest decrease was observed in Hispanic White women aged 40-49 years.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2022)

Article Oncology

Systemic Therapy for Advanced Human 3 Epidermal Growth Factor Receptor 2-Positive Breast Cancer: ASCO Guideline Update

Sharon H. Giordano et al.

Summary: The purpose of this study is to update guideline recommendations for systemic therapy in HER2-positive advanced breast cancer patients. Based on a systematic literature review, recommendations were made including the use of HER2-targeted therapy and evaluation on a case-by-case basis.

JOURNAL OF CLINICAL ONCOLOGY (2022)

Article Medicine, General & Internal

Trastuzumab Deruxtecan versus Trastuzumab Emtansine for Breast Cancer

J. Cortes et al.

Summary: Among patients with HER2-positive metastatic breast cancer previously treated with trastuzumab and a taxane, trastuzumab deruxtecan was associated with a lower risk of disease progression or death compared to trastuzumab emtansine. However, treatment with trastuzumab deruxtecan was associated with interstitial lung disease and pneumonitis.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

Article Oncology

Association of Medicaid Expansion With Mortality Disparity by Race and Ethnicity Among Patients With De Novo Stage IV Breast Cancer

Catalina Malinowski et al.

Summary: This study examined the association between Medicaid expansion and mortality disparity among patients with de novo stage IV breast cancer. The results showed that after Medicaid expansion, the survival disparity between racial and ethnic minority groups and White patients significantly decreased, and the mortality rate also decreased.

JAMA ONCOLOGY (2022)

Article Oncology

Cancer treatment and survivorship statistics, 2022

Kimberly D. Miller et al.

Summary: The number of cancer survivors in the United States is increasing due to population growth, aging, and improved detection and treatment. The most prevalent cancers are prostate, skin melanoma, and colon and rectum for males, and breast, uterine corpus, and thyroid for females. Treatment disparities exist, with Black patients being less likely to be diagnosed with early-stage cancer and having lower surgical receipt rates.

CA-A CANCER JOURNAL FOR CLINICIANS (2022)

Editorial Material Medicine, General & Internal

The Emergence of the Racial Disparity in US Breast-Cancer Mortality

Ismail Jatoi et al.

Summary: The racial disparity in breast-cancer mortality in the United States is due to the unequal benefit derived by Black women from interventions such as mammography screening and adjuvant endocrine therapy. Removing barriers to health care access could help mitigate the racial divide in breast-cancer mortality.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

Article Medicine, General & Internal

Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer

Shanu Modi et al.

Summary: Trastuzumab deruxtecan demonstrated significantly longer progression-free and overall survival compared to physician's choice chemotherapy in patients with HER2-low metastatic breast cancer.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

Article Oncology

Regional Nodal Management in the Setting of Up-Front Surgery

Lior Z. Braunstein et al.

Summary: Axillary lymph node dissection has traditionally been considered necessary for breast cancer treatment, but recent studies have shown that sentinel lymph node biopsy and nodal irradiation can achieve similar outcomes with lower rates of recurrence and improved quality of life. This chapter explores the evolving approaches to regional nodal management and the importance of tailored patient selection.

SEMINARS IN RADIATION ONCOLOGY (2022)

Article Oncology

Estimation of the Number of Individuals Living With Metastatic Cancer in the United States

Lisa Gallicchio et al.

Summary: This study estimated the number of individuals living with metastatic breast, prostate, lung, colorectal, or bladder cancer or metastatic melanoma in the United States using population-based data. The results showed an increasing trend in the number of patients with metastatic cancer across the six most common cancer types.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2022)

Article Oncology

Neighborhood-Level Redlining and Lending Bias Are Associated with Breast Cancer Mortality in a Large and Diverse Metropolitan Area

Lindsay J. Collin et al.

Summary: The study revealed that living in redlined areas significantly increases breast cancer mortality, while residing in areas with pronounced lending bias decreases breast cancer mortality. Non-Hispanic Black and Non-Hispanic White women experience different levels of mortality under these influences, highlighting the need for further research.

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2021)

Article Oncology

Race, Ethnicity, and Clinical Outcomes in Hormone Receptor-Positive, HER2-Negative, Node-Negative Breast Cancer in the Randomized TAILORx Trial

Kathy S. Albain et al.

Summary: The study revealed that black women with early breast cancer had worse clinical outcomes despite similar 21-gene recurrence score results and comparable systemic therapy. Hispanic ethnicity and Asian race were associated with better outcomes.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2021)

Article Oncology

Final results from the PERUSE study of first-line pertuzumab plus trastuzumab plus a taxane for HER2-positive locally recurrent or metastatic breast cancer, with a multivariable approach to guide prognostication

D. Miles et al.

Summary: The combination of pertuzumab and trastuzumab with investigator-selected taxane in the treatment for HER2-positive LR/mBC shows consistent safety and efficacy compared to previous studies. Exploratory analyses suggest potential risk factors that may influence treatment outcomes.

ANNALS OF ONCOLOGY (2021)

Article Oncology

Neighborhood Social Environmental Factors and Breast Cancer Subtypes among Black Women

Bo Qin et al.

Summary: This study evaluated the association between neighborhood-level socioeconomic status and breast cancer subtypes among Black women, finding that Black women living in socioeconomically disadvantaged neighborhoods have an increased risk of triple-negative breast cancer, particularly in areas with lower proportions of Black residents. The findings suggest that where people live may influence breast tumor biology, highlighting the need for a deeper understanding of multilevel pathways contributing to tumor biology.

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2021)

Article Oncology

Breast Cancer Risk Factors and Survival by Tumor Subtype: Pooled Analyses from the Breast Cancer Association Consortium

Anna Morra et al.

Summary: Modifiable lifestyle factors such as BMI, smoking, physical activity, and age at first pregnancy are strongly associated with 10-year all-cause mortality among breast cancer patients. Associations were similar across different subtypes of breast cancer.

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2021)

Article Oncology

Neoadjuvant Chemotherapy, Endocrine Therapy, and Targeted Therapy for Breast Cancer: ASCO Guideline

Larissa A. Korde et al.

Summary: The guideline recommendations for neoadjuvant therapy for breast cancer suggest that patients should be managed by multidisciplinary teams and that appropriate candidates include those with inflammatory breast cancer or residual disease that may prompt a change in therapy.

JOURNAL OF CLINICAL ONCOLOGY (2021)

Article Oncology

Breast cancer patients' insurance status and residence zip code correlate with early discontinuation of endocrine therapy: An analysis of the ECOG-ACRIN TAILORx trial

Gelareh Sadigh et al.

Summary: This study found that patients with breast cancer who were Medicaid or self-pay and those in the highest quartile of neighborhood deprivation scores were more likely to discontinue endocrine therapy early. These social determinants of health become more important given the rise in unemployment and loss of insurance coverage during the COVID-19 pandemic. Early identification of at-risk patients and enrollment in insurance optimization programs may improve treatment adherence.

CANCER (2021)

Article Oncology

Cancer Mortality Disparities among Asian American and Native Hawaiian/Pacific Islander Populations in California

Heidy N. Medina et al.

Summary: The study revealed that although AANHPI populations have lower overall cancer mortality rates, they exhibit considerable heterogeneous patterns, with significantly higher rates of certain cancers among Native Hawaiian and Pacific Islanders and Southeast Asians. South Asians showed lower cancer mortality rates.

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2021)

Review Pharmacology & Pharmacy

Emerging drugs for the treatment of triple-negative breast cancer: a focus on phase II immunotherapy trials

Peter E. Hall et al.

Summary: Triple-negative breast cancer is characterized by aggressive behavior and poor outcomes compared to other subtypes. While chemotherapy remains the main treatment modality, recent advances have shown the benefit of adding immune checkpoint inhibitors to therapy regimens. Further research is needed to improve outcomes and develop more effective predictive biomarkers.

EXPERT OPINION ON EMERGING DRUGS (2021)

Article Oncology

Evaluation of Racial/Ethnic Differences in Treatment and Mortality Among Women With Triple-Negative Breast Cancer

Beomyoung Cho et al.

Summary: This study examined the differences in treatment and outcomes between African American and White women with TNBC, finding that African American women had lower odds of receiving surgery and chemotherapy compared to White women, leading to a significantly higher risk of breast cancer mortality.

JAMA ONCOLOGY (2021)

Article Oncology

Cancer statistics for the US Hispanic/Latino population, 2021

Kimberly D. Miller et al.

Summary: The Hispanic/Latino population accounts for 18% of the total population in the continental United States and Hawaii. While their cancer incidence and mortality rates are lower compared to non-Hispanic Whites, they have higher rates of certain types of cancer such as liver and stomach cancer, indicating the need for improved cancer prevention strategies.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Article Surgery

Trends in Contralateral Prophylactic Mastectomy Utilization for Small Unilateral Breast Cancer

Alison S. Baskin et al.

Summary: For women with small, unilateral breast cancer, most are suitable candidates for breast conserving surgery (BCS) but a significant portion opt for mastectomy, with a rising percentage choosing contralateral prophylactic mastectomy (CPM). Factors such as patient characteristics, tumor attributes, and facility features may influence the decision-making regarding CPM.

JOURNAL OF SURGICAL RESEARCH (2021)

Article Oncology

Annual Report to the Nation on the Status of Cancer, Part 1: National Cancer Statistics

Farhad Islami et al.

Summary: This study provides updated data on cancer incidence, mortality, and survival rates in the United States, finding that overall cancer incidence continues to increase in females, children, and adolescents, while overall death rates are declining, especially for lung cancer and melanoma. For several major cancer types, however, death rates are still increasing or declining at a slower pace.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2021)

Article Oncology

Neighborhood disadvantage and individual-level life stressors in relation to breast cancer incidence in US Black women

Lauren E. Barber et al.

Summary: In this large cohort study of Black women, neighborhood disadvantage and lower neighborhood SES were associated with an approximately 25% increased risk of ER- breast cancer. On the individual level, childhood sexual abuse and marital status were associated with a higher risk of ER+ breast cancer. Further research is needed to understand the underlying reasons for these associations.

BREAST CANCER RESEARCH (2021)

Article Oncology

Breast cancer patients' insurance status and residence zip code correlate with early discontinuation of endocrine therapy: An analysis of the ECOG-ACRIN TAILORx trial

Gelareh Sadigh et al.

Summary: The study found that insurance coverage and neighborhood deprivation index at study entry can impact early discontinuation of endocrine therapy in breast cancer patients, with uninsured or underinsured patients more likely to discontinue treatment.

CANCER (2021)

Article Demography

The Immigrant Health Advantage: An Examination of African-Origin Black Immigrants in the United States

Justin Vinneau Palarino

Summary: The study shows that African-origin black immigrants have lower odds of obesity, hypertension, and diabetes compared to U.S.-born non-Hispanic blacks, regardless of their duration in the United States. Additionally, African-origin black immigrants display similar probabilities of reporting overweight, obesity, and diabetes as non-Hispanic white and Mexican-American immigrants across different duration categories. These findings suggest that African-origin black immigrants may experience immigrant health advantage despite potential discriminatory behaviors.

POPULATION RESEARCH AND POLICY REVIEW (2021)

Review Surgery

Role of Preoperative MRI in the Management of Newly Diagnosed Breast Cancer Patients

Lisa A. Newman

JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2020)

Article Medicine, General & Internal

Pembrolizumab for Early Triple-Negative Breast Cancer

Peter Schmid et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Review Medicine, General & Internal

Systemic Therapy for Estrogen Receptor-Positive, HER2-Negative Breast Cancer

Harold J. Burstein

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Review Medicine, General & Internal

Breast Cancer Treatment A Review

Adrienne G. Waks et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)

Article Oncology

Differences in breast cancer outcomes amongst Black US-born and Caribbean-born immigrants

Priscila Barreto-Coelho et al.

BREAST CANCER RESEARCH AND TREATMENT (2019)

Article Oncology

Trends in stage at diagnosis for young breast cancer patients in the United States

Carol E. DeSantis et al.

BREAST CANCER RESEARCH AND TREATMENT (2019)

Article Medicine, General & Internal

Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer

G. von Minckwitz et al.

NEW ENGLAND JOURNAL OF MEDICINE (2019)

Article Oncology

Cancer Statistics, 2018

Rebecca L. Siegel et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2018)

Article Medicine, General & Internal

Association of Screening and Treatment With Breast Cancer Mortality by Molecular Subtype in US Women, 2000-2012

Sylvia K. Plevritis et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)

Article Medicine, General & Internal

Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer

J. A. Sparano et al.

NEW ENGLAND JOURNAL OF MEDICINE (2018)

Review Oncology

Recent Advances in the Treatment of Breast Cancer

Christy W. S. Tong et al.

FRONTIERS IN ONCOLOGY (2018)

Article Oncology

Proportion of US Trends in Breast Cancer Incidence Attributable to Long-term Changes in Risk Factor Distributions

Ruth M. Pfeiffer et al.

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2018)

Article Medicine, General & Internal

Adjuvant Capecitabine for Breast Cancer after Preoperative Chemotherapy

N. Masuda et al.

NEW ENGLAND JOURNAL OF MEDICINE (2017)

Article Medicine, General & Internal

Screening for Breast Cancer: US Preventive Services Task Force Recommendation Statement

Albert L. Siu et al.

ANNALS OF INTERNAL MEDICINE (2016)

Article Oncology

Delayed Initiation of Adjuvant Chemotherapy Among Patients With Breast Cancer

Mariana Chavez-MacGregor et al.

JAMA ONCOLOGY (2016)

Article Medicine, General & Internal

Differences in Breast Cancer Stage at Diagnosis and Cancer-Specific Survival by Race and Ethnicity in the United States

Javaid Iqbal et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)

Review Medicine, General & Internal

Breast Cancer Screening for Women at Average Risk 2015 Guideline Update From the American Cancer Society

Kevin C. Oeffinger et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)

Article Oncology

Estrogen Receptor Status and the Future Burden of Invasive and In Situ Breast Cancers in the United States

Philip S. Rosenberg et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)

Article Surgery

Nationwide Trends in Mastectomy for Early-Stage Breast Cancer

Kristy L. Kummerow et al.

JAMA SURGERY (2015)

Article Oncology

Estrogen Receptor Status and the Future Burden of Invasive and In Situ Breast Cancers in the United States

Philip S. Rosenberg et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)

Article Oncology

Effects of Screening and Systemic Adjuvant Therapy on ER-Specific US Breast Cancer Mortality

Diego Munoz et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2014)

Article Oncology

Receipt of locoregional therapy among young women with breast cancer

Rachel A. Freedman et al.

BREAST CANCER RESEARCH AND TREATMENT (2012)

Review Oncology

Cancer treatment and survivorship statistics, 2012

Rebecca Siegel et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2012)

Article Oncology

Breast Cancer Incidence Rates in U.S. Women Are No Longer Declining

Carol DeSantis et al.

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2011)

Article Oncology

Incidence of Breast Cancer in the United States: Current and Future Trends

William F. Anderson et al.

JOURNAL OF THE NATIONAL CANCER INSTITUTE (2011)

Article Oncology

The impact of changes in hormone therapy on breast cancer incidence in the US population

Nathan J. Coombs et al.

CANCER CAUSES & CONTROL (2010)

Article Medicine, General & Internal

The decrease in breast-cancer incidence in 2003 in the United States.

Peter M. Ravdin et al.

NEW ENGLAND JOURNAL OF MEDICINE (2007)

Article Medicine, General & Internal

Effect of screening and adjuvant therapy on mortality from breast cancer

DA Berry et al.

NEW ENGLAND JOURNAL OF MEDICINE (2005)